Search Orphan Drug Designations and Approvals
-
Generic Name: | umbralisib |
---|---|
Date Designated: | 03/04/2020 |
Orphan Designation: | Treatment of Follicular Lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
TG Therapeutics, Inc. 2 Gansevoort Street 9th Floor New York, New York 10014 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-